Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer

Advances in Radiation Oncology
Christian EkangerOlav Dahl

Abstract

There is no consensus on how to treat high-risk prostate cancer, and long-term results from hypofractionated radiation therapy are lacking. We report 10-year results after image guided, intensity modulated radiation therapy with hypofractionated simultaneous integrated boost and elective pelvic field. Between 2007 and 2009, 97 consecutive patients with high-risk prostate cancer were included, treated with 2.7 to 2.0 Gy × 25 Gy to the prostate, seminal vesicles, and elective pelvic field. Toxicity was scored according to Radiation Therapy Oncology Group criteria and biochemical disease-free survival (BFS) defined by the Phoenix definition. Patients were subsequently divided into 3 groups: high risk (HR; n = 32), very high risk (VHR; n = 50), and N+/s-prostate-specific antigen (PSA) ≥100 (n = 15). Differences in outcomes were examined using Kaplan-Meier analyses. BFS in the patients at HR and VHR was 64%, metastasis-free survival 80%, prostate cancer-specific survival 90%, and overall survival (OS) 72%. VHR versus HR subgroups demonstrated significantly different BFS, 54% versus 79% (P = .01). Metastasis-free survival and prostate cancer-specific survival in the VHR group versus HR group were 76% versus 87% (P = .108) and 74% ver...Continue Reading

References

Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·J D CoxT F Pajak
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John J CoenWilliam U Shipley
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie T H PeetersJoos V Lebesque
Sep 4, 2007·International Journal of Radiation Oncology, Biology, Physics·Deborah A KubanAlan Pollack
Jul 6, 2010·International Journal of Radiation Oncology, Biology, Physics·Arne SolbergAnders Angelsen
Jun 15, 2011·International Journal of Radiation Oncology, Biology, Physics·Rahul D TendulkarPatrick A Kupelian
Feb 15, 2012·International Journal of Radiation Oncology, Biology, Physics·Michael J ZelefskyMargie Hunt
Sep 13, 2012·Acta Oncologica·Alexandru Dasu, Iuliana Toma-Dasu
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan PollackMark K Buyyounouski
Nov 6, 2013·Prostate Cancer and Prostatic Diseases·D SundiA E Ross
May 9, 2014·Journal of the National Comprehensive Cancer Network : JNCCN·James L MohlerUNKNOWN National Comprehensive Cancer Network
Jul 17, 2015·JAMA Oncology·Anusha KalbasiJustin E Bekelman
Jan 7, 2016·Journal of the National Comprehensive Cancer Network : JNCCN·James L MohlerDeborah A Freedman-Cass
Feb 9, 2016·International Journal of Radiation Oncology, Biology, Physics·Amol K NarangTheodore L DeWeese
Feb 19, 2016·BJU International·Mann AngMichael E O'Callaghan
Apr 6, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W Robert LeeHoward M Sandler
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles N CattonMark N Levine
Jun 27, 2018·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Liv B HysingSara Thörnqvist
Oct 15, 2018·The Lancet Oncology·Guila Delouya, Daniel Taussky
Oct 26, 2018·Lancet·Christopher C ParkerUNKNOWN Systemic Therapy for Advanced or Metastatic Prostate cancer: Evaluation of Drug Efficacy (STAMPEDE) investigators
Feb 6, 2019·International Journal of Radiation Oncology, Biology, Physics·Ibrahim Abu-GheidaRahul D Tendulkar

❮ Previous
Next ❯

Citations

Oct 24, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Sophie D FossåTor A Myklebust
Oct 5, 2021·Medical Physics·Øyvind Lunde RørtveitSara Pilskog

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection
biopsy

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.